We have news we have been waiting to share.
This week, the FDA cleared the way for the first-ever gene therapy clinical trial for children with INAD, the disease that took my brothers Bridger and Essex. This is the therapy INADcure has spent years working toward.
You can read INADcure’s full announcement here.
For a disease with no approved treatments, reaching the point of a human trial is a milestone that once felt impossibly far away. It is a clearance to begin testing, not a cure, and there is still a long road ahead. But it is real progress.
Through the Bridger & Essex Grebe Fund, this community has raised more than $1 million for the fight against INAD. The fight is not over, but a moment like this is worth stopping to celebrate.
My brothers never had the chance to benefit from a treatment like this. Thanks to your support, other children will have that opportunity.
Thank you again for your generosity and support. Our family is extremely grateful.
Best,Tripp Grebe
